Cipla’s wholly owned step-down subsidiary in USA -- InvaGen Pharmaceuticals has entered into a Share Repurchase agreement on July 25, 2022 with Avenue Therapeutics (Avenue) and Fortress Biotech, for sale of 5,833,333 shares representing 25.93% of equity stake (on a fully diluted basis) held in Avenue for a consideration of $3 million and an additional amount upto $4 million on satisfaction of certain conditions.
The consideration amount is subject to completion of closing conditions and future financing by Avenue. On completion of the repurchase, Avenue shall cease to be an associate of the Company.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1671.20 |
| Dr. Reddys Lab | 1235.00 |
| Cipla | 1237.85 |
| Zydus Lifesciences | 942.05 |
| Lupin | 2330.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: